FEMARA 2,5 mg Filmtabletten BB FARMA

Description

Side effects

As a rule, adverse effects are mild to moderate in severity and are mainly related to inhibition of oestrogen synthesis.

The incidence of adverse effects is estimated as follows: incidence “very common” – >10%, “common” – ≥1 – <10%, “rare” – ≥0.1% – <1%, “rare” – >0.01 – <0.1%, “very rarely” – <0.01%, including isolated reports.

Infectious and parasitic diseases:

Rare – urinary tract infections.

Benign, malignant and unspecified tumours (including cysts and polyps):

Rare – pain in the tumour area.

Blood and lymphatic system disorders:

Rare – leukopenia.

Immune system disorders:

Frequency unknown – anaphylactic reactions.

Metabolic and nutritional disorders:

Very common – hypercholesterolaemia; common – anorexia, increased appetite.

Psychiatric disorders:

Frequent – depression; rare – anxiety (including nervousness), irritability.

Nervous system disorders:

Common – headache, dizziness; rare – somnolence, insomnia, memory impairment, sensory disturbances (including paresthesia, hypoaesthesia), taste disturbances, episodes of cerebral circulatory disturbances, carpal tunnel syndrome.

Visual disturbances:

Rare – cataracts, eye irritation, ‘blurred’ vision.

Cardiac disorders:

Rare – palpitations*, tachycardia, ischaemic heart disease (including first time onset or worsening of existing angina, angina requiring surgical intervention, myocardial infarction, myocardial ischaemia).

Vascular disorders:

Very common – hot flashes (“hot flashes”); common – elevated blood pressure (BP); uncommon – thrombophlebitis (including superficial and deep thrombophlebitis); rare – pulmonary embolism, arterial thrombosis, stroke.